Segment Information (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Schedule of segment reporting information

Information for the Company's reportable segments for the years ended December 31, 2018, December 31, 2017, and December 31, 2016 are as follows:

Year Ended December 31, 2018	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	838,142	—	—	$	838,142
Loss from operations	$	1,975,792	11,887,108	8,211,323	$	22,074,223
Interest income, net	$	—	—	152,006	$	152,006

Year Ended December 31, 2017	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	1,274,499	—	—	$	1,274,499
Loss from operations	$	8,877,330	16,715,752	9,132,544	$	34,725,626
Interest income, net	$	—	—	291,964	$	291,964

Year Ended December 31, 2016	Consumer Operations		Drug Development	Corporate	Consolidated
Total revenue	$	1,010,663	—	—	$	1,010,663
Loss from operations	$	10,023,137	19,620,338	10,242,757	$	39,886,232
Interest income, net	$	—	—	393,109	$	393,109